General enquiries

+44 (0) 20 7079 4399

Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat

Our Hospitals

Sarah Cannon Research UK

Sarah Cannon Research UK  is a unique standalone trial facility that collaborates and works closely with clinical investigators to develop new and innovative cancer therapies for patients.

Sarah Cannon Research UK is part of the Hospital Corporation of America (HCA) network, which comprises six central London hospitals and an expert group of 60 oncologists making up our Leaders in Oncology Care (LOC). We specialise in the development of novel cancer therapies and provide a clinical research option for cancer patients in London and the United Kingdom.

Sarah Cannon Research UK is the first trials unit outside the NHS that has the ability to offer new anti-cancer drugs in clinical trials. As a dedicated trials unit we are focused on fast study set-up time lines to offer patients rapid access to new investigational drug therapies – importantly we are open for both private and NHS patients.

The Harley Street Clinic
The Lister Hospital
The Lister Fertility Clinic
London Bridge Hospital
The Portland Hospital
The Princess Grace Hospital
Wellington hospital
HCA Healthcare UK at The Shard
The Harley Street Clinic Children's Hospital
Harley Street Queens
Harley Street at University College Hospital
The Christie Clinic
Sarah Cannon Research UK
Blossoms Healthcare
HCA Laboratories
Roodlane Medical
The Wilmslow Hospital
Galen Health Partners
The London Gamma Knife Centre at St Bartholomew's
HCA Healthcare UK

© copyright 2008 - 2017 HCA Healthcare UK.

Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.